Learning content that survives medical review.
Pharmaceutical training carries a constraint most corporate learning does not. Being roughly right is not acceptable, and every piece of content has to hold up under review in every market it ships to.
What makes pharmaceutical e-learning different?
Review. Every claim has to be traceable, every reference has to be checkable, and the same content has to hold its accuracy across markets with different regulatory positions. That changes how the content is structured, not just how it is checked.
Julia Mattey worked alongside Pfizer's Medical Review Excellence team on exactly this problem, restructuring medical content and building reusable master decks across more than 20 pharmaceutical products.
Why does pharmaceutical training go out of date so quickly?
Because products, indications and guidance move faster than the production model behind the training. When every update requires an external agency brief, the training is permanently a version behind the product.
The fix is structural. On the Roche Diabetes Care programme, Julia Mattey replaced agency-produced training with reusable templates and an in-house production process, which reduced external agency costs by 40% and let affiliates republish without a new brief.
How is multilingual pharmaceutical content handled?
Localisation has to be part of the template structure from the start rather than applied to finished modules. Retrofitting it is where multilingual pharmaceutical training loses most of its budget.
The Roche Diabetes Care catalogue was built for global affiliates from the beginning, and held completion and satisfaction rates above 90% across those markets.
Work in this sector.
Complex medical presentation content under tight timelines, with scientific accuracy and brand compliance to hold. Julia Mattey restructured it into reusable master decks across more than 20 pharmaceutical products.
Read the case study →Training for rapidly evolving HCP-facing software was going out of date faster than the agency model could keep up with. Julia Mattey designed a global blueprint and production process in Articulate Rise, catalogued in Cornerstone.
Read the case study →Complex and regulated financial concepts made understandable for audiences from young learners to adults making investment decisions, localised across English, French, Spanish and German.
Read the case study →Common questions.
Does Julia Mattey have pharmaceutical experience?
Yes. She worked with Pfizer's Medical Review Excellence team on master presentation decks across more than 20 pharmaceutical products, and designed the training production model for Roche Diabetes Care and mySugr across global affiliates.
Can e-learning content be built to pass medical review?
It can be built so that review is cheaper and repeatable. That means structuring content so accuracy, references and compliance are verified once at component level and reused, rather than re-checked from scratch on every new deck or module.
Who is this work usually for inside a pharmaceutical company?
Medical affairs, medical education, commercial training and global L&D functions, particularly where the same material has to reach multiple affiliate markets.
How this usually starts.
Tell me what is not working.
If your training is expensive to maintain, slow to update, or not landing with the people it is for, I can usually tell you fairly quickly whether that is a content problem, a platform problem or a process problem.